Recent Company News

• 10:03 AM ET Jan 15, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (250 total)

• 01:24 AM ET Jan 05, 2026
  

  Insider transaction: Burning Rock Biotech chairman/CEO Yusheng Han discloses purchase of $812K of ADSs ($19.68, 0.00)

• 10:02 AM ET Dec 23, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (170 total)

• 10:04 AM ET Dec 04, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (132 total)

• 10:04 AM ET Nov 25, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (161 total)

• 10:11 AM ET Nov 20, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (125 total)

• 01:59 AM ET Nov 20, 2025
  

  Burning Rock Biotech reports Q3 EPS (CNY0.16) vs year-ago (CNY0.35) ($16.03, 0.00)

• 10:06 AM ET Nov 03, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (194 total)

• 10:02 AM ET Oct 27, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (168 total)

• 02:47 AM ET Sep 24, 2025
  

  Japan approves Burning Rock Biotech's OncoGuide OncoScreen Plus CDx System for use with capivasertib in breast cancer ($9.18, 0.00)